Navigation Links
Sigma-tau's Antimalarial Awarded "Project of the Year" 2011 by Medicines for Malaria Venture

NEW DELHI, November 27, 2012 /PRNewswire/ --

The project team for Eurartesim®, dihydroartemisinin-piperaquine (DHA-PQP), the first novel chemical entity developed by Sigma-Tau was awarded Medicines for Malaria (MMV) Project of the Year 2011, the latter is a non-profit body with significant contribution from the Bill& Melinda Gates foundation. The award was presented in new Delhi during MMV's international stakeholder meeting.

Representatives of the Italian pharma group - Prof. Trevor Jones, Dr Marco Corsi & Dr Andreas Diedenhofen - accepted the prize and expressed satisfaction on behalf of the entire team for the achievement.

MMV established the "Project of the Year" award more than a decade ago to recognize the efforts of selected teams working to combat malaria worldwide. Winners are selected by MMV's Expert Scientific Advisory Committee, a group of world renowned experts in malaria and drug development.

Having received European Medicines Agency (EMA) approval in 2011, Eurartesim can now be used safely and effectively, and be deployed widely. The first shipment of 160,000 packages of Eurartesim to a malaria-endemic country were delivered to Cambodia in July this year, where it is hoped the medicine will help to delay the development of artemisinin drug resistance emerging in the region.

The drug is already available in Europe and has a series of advantages over other artemisinin-based combination therapies (ACTs) given that it's easier to administer - once a day for three days- rather than other medicines which need to be taken twice a day. owing to the long half-life of piperaquine, Eurartesim® offers better and longer protection from new malaria infections.

Sigma-Tau Group

Sigma-Tau is a leading, all Italian capital, International pharmaceutical Group, founded in 1957, that invests in the research, development and marketing of innovative and effective treatments to improve human well-being and quality of life. Sigma-Tau Group has headquarters in Pomezia (Rome, Italy), and subsidiaries in France, Switzerland, the Netherlands, Belgium, Portugal, Germany, UK, India, and with production plant in Italy as well as in Spain and US (Indianapolis); with about 2400 employees and an extensive network of licensees worldwide achieved a global turnover of € 663 million in 2011.


Sigma-Tau Press Office Evolution
Bruno Chiavazzo, Head of Communication and Information
Phone +39-(0)6-91393963
Rudra Chakraborty
Phone +39-3317671004

SOURCE Sigma-Tau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Reveals Extent of Poor-Quality Antimalarial Medicines in South American Countries
2. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
3. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
4. Breast Cancer Survivor Awarded Top Prize In 2012 Oncology On Canvas(SM) Art Competition
5. New Snoring Therapy Awarded The Prestigious Spark Award
6. Harrisvaccines Awarded Vaccine Product Licensure
7. Healionics Awarded $900k Grant from NIH
8. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
9. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
10. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
11. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
Post Your Comments:
(Date:11/26/2015)... 26, 2015 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ... which demands kidney transplantation is expected to boost the market ... for organ transplantation. --> 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... Research and Markets ( ) has announced the ... Type (Dressings, Therapy Devices, Active Wound Care), Application (Surgical ... Geography - Global Forecast to 2020" report to ... --> The purpose of this report is to ... advanced wound care market. It involves deep dive analysis ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... double board certified facial plastic surgeon specializing in both surgical and non-surgical treatments, ... The Skin Spa at Hobgood Facial Plastic Surgery. , Highly trained and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s ... learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions ... 65 years, Brillianteen has been a treasured tradition for numerous families in the ...
(Date:11/25/2015)... PA (PRWEB) , ... November 25, 2015 , ... “While ... said an inventor, from Bronx, N.Y. “I thought there had to be a convenient ... invented the PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood Treatment ... struggling with eating disorders as a result of the $20,000 raised at the ... at Fox Run Golf Club in Eureka, will help individuals who otherwise might ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
Breaking Medicine News(10 mins):